COG6

COG6 is a subunit of the conserved oligomeric Golgi (COG) complex that functions as a vesicle-tethering factor essential for retrograde intra-Golgi transport and Golgi homeostasis. COG6 interacts with a subset of Golgi SNAREs—STX5, STX6, GS27, and SNAP29—via a universal SNARE-binding motif, and this interaction is required for COG6 Golgi localization and maintenance of Golgi integrity (PMID:23057818). Loss of COG6 destabilizes STX6 and other COG subunits, delays retrograde Golgi trafficking, impairs cell-surface sialic acid presentation, and upregulates lysosome-dependent protein degradation (PMID:23606727, PMID:41362306, PMID:40910953). Biallelic loss-of-function variants in COG6 cause a congenital disorder of glycosylation characterized by intellectual disability and additional multisystem features (PMID:23606727, PMID:41362306).

1. 2012 High

   Identifying how COG6 engages the vesicle fusion machinery: COG6 was shown to bind Golgi SNAREs (STX5, STX6, GS27, SNAP29) through a conserved SNARE-binding motif, and deletion of this motif abolished Golgi localization and the ability to perturb Golgi morphology, establishing SNARE interaction as the primary mechanism anchoring COG6 at the Golgi and mediating its role in Golgi integrity.

   Evidence Yeast two-hybrid, co-immunoprecipitation, domain-deletion mutagenesis, and overexpression/depletion studies with Golgi morphology readouts in mammalian cells

   PMID:23057818

   Open questions at the time

   • Structural basis of the COG6–SNARE interaction is unresolved
   • Whether COG6 engages SNAREs simultaneously or sequentially is unknown
   • Contribution of individual SNARE partners to COG6 function was not dissected
2. 2013 Medium

   Linking COG6 loss to human disease and SNARE stability: patient cells lacking functional COG6 showed pronounced reduction of STX6 protein, demonstrating that COG6 stabilizes at least one of its SNARE partners in vivo and that COG6 deficiency causes a clinical syndrome with intellectual disability and hypohidrosis.

   Evidence Protein quantification in patient-derived cells, autozygosity mapping, and exome sequencing

   PMID:23606727

   Open questions at the time

   • Mechanism by which COG6 stabilizes STX6 (direct protection vs. indirect trafficking effect) is not established
   • No rescue experiment was performed to confirm causality of the COG6 variant
   • Transferrin glycosylation was normal, leaving the glycosylation spectrum of COG6 deficiency incompletely defined
3. 2025 High

   Defining the broader cellular consequences of COG6 loss: COG6 knockout impairs surface sialic acid presentation through disrupted Golgi homeostasis and independently upregulates lysosomal degradation of proteins, demonstrating dual downstream effects—glycosylation defects and enhanced lysosomal catabolism—that are separable and rescued by lysosomal inhibitors.

   Evidence Genome-wide CRISPR/Cas9 knockout screen, COG6 KO functional assays with lysosomal inhibitor rescue, surface sialic acid quantification, and protein interaction analysis in human cells

   PMID:40910953

   Open questions at the time

   • How COG6 loss triggers lysosomal upregulation is mechanistically undefined
   • Whether enhanced lysosomal degradation is a general consequence of COG complex disruption or specific to COG6 is untested
4. 2025 Medium

   Establishing COG6 as essential for retrograde Golgi transport and COG complex stability: a truncating COG6 variant abolishing protein expression impaired cooperating COG subunit levels and delayed retrograde transport, confirming COG6 as a structural requirement for both the COG complex and its trafficking function.

   Evidence Retrograde transport assays, COG subunit expression analysis, and MALDI mass spectrometry glycan profiling in patient cells

   PMID:41362306

   Open questions at the time

   • Which specific COG subunits depend on COG6 for stability and the hierarchy of subunit interdependence are not fully mapped
   • No reconstitution with purified components to demonstrate direct structural role

• Open question: the structural basis of COG6 integration into the COG complex, the mechanism by which COG6 loss upregulates lysosomal activity, and the full spectrum of glycosylation defects attributable specifically to COG6 remain unresolved.
• No high-resolution structure of COG6 within the octameric COG complex
• Causal pathway from COG6 loss to enhanced lysosomal degradation is unknown
• Comprehensive glycoproteomics of COG6-deficient cells has not been performed